Malcolm McColl
Algemeen Directeur bij Viralytics Ltd.
Profiel
Malcolm L.
McColl is the founder and currently serves as the Chairman & Chief Executive Officer of ImmVirX Pty Ltd., a company founded in 2019.
He is also the Chief Executive Officer of Viralytics Ltd., a position he has held since 2013.
In his former roles, Dr. McColl served as the CEO, Director & Managing Director of Viralytics Pty Ltd.
He was also the Vice President-Global Business Development at Mayne Pharma, Inc. from 2007 to 2010.
Additionally, he held the position of Vice President-Business Development at Starpharma Holdings Ltd.Dr. McColl's education includes an MBA from Melbourne Business School and an undergraduate degree from the University of Melbourne.
Actieve functies van Malcolm McColl
| Bedrijven | Functie | Begin |
|---|---|---|
| Viralytics Ltd. | Algemeen Directeur | 01-01-2013 |
ImmVirX Pty Ltd.
 ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Algemeen Directeur | 01-01-2019 |
Eerdere bekende functies van Malcolm McColl
| Bedrijven | Functie | Einde |
|---|---|---|
Mayne Pharma, Inc.
 Mayne Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mayne Pharma, Inc. develops pharmaceutical products. Its services include pharmaceutical development, clinical trial materials, method development and validation, trace metals, stability, and microbiology services. The company was founded in 1994 and is headquartered in Greenville, NC. | Corporate Officer/Principal | 01-01-2010 |
| VIRALYTICS LTD. | Algemeen Directeur | - |
| STARPHARMA HOLDINGS LIMITED | Corporate Officer/Principal | - |
Opleiding van Malcolm McColl
| Melbourne Business School | Masters Business Admin |
| University of Melbourne | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Mayne Pharma, Inc.
Mayne Pharma, Inc. Pharmaceuticals: MajorHealth Technology Mayne Pharma, Inc. develops pharmaceutical products. Its services include pharmaceutical development, clinical trial materials, method development and validation, trace metals, stability, and microbiology services. The company was founded in 1994 and is headquartered in Greenville, NC. | Health Technology |
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
ImmVirX Pty Ltd.
ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Commercial Services |
| Viralytics Ltd. |
